One study presented in the journal — from a group led by Patrick Singleton, PhD, assistant professor of medicine at the University of Chicago Medicine — shows how opioids already present in the body can enhance the malignant tendencies of human
lung cancer cells transplanted into mice, even without the addition of morphine.
Not exact matches
$ 1.8 M Supports
Cancer Drug Discovery on Commonly Mutated Gene New Brunswick Patch — April 5, 2016 Behavioral Scientist Shares Insights about FDA's Proposed Rule on Banning Tanning Bed Use among Minors News-Medical.net - March 19, 2016 Intervention Program Reduces Caregiver Distress during Hospitalization of Pediatric Stem
Cell Transplant Patients News-Medical.net - March 9, 2016 Exploring Genomic Pathways in the Development of Ovarian
Cancer GMNews.com - March 2, 2016 Differences in Type of Small Protein may further Elucidate
Lung Cancer Risk in African Americans ScienceDaily.com - March 2, 2016 Study Looks at Post-Treatment Resources for Prostate
Cancer Patients Transitioning to Survivorship News-Medical.net - February 11, 2016 Drawing the Line on Tanning Bed Use by Teens ScienceDaily.com - December 21, 2015 What Rutgers Study Uncovered about E-Cigarette Use NJBiz.com - December 9, 2015 Identification of Barrier that Prevents Progression of Benign Kidney Tumors to Malignant Disease MedicalNewsToday.com - November, 24, 2015 What is the Color of the
Lung Cancer Ribbon?
In this study, human
lung cancer cells with additional copies of the opioid receptor grew more than twice as fast as tumor
cells that lacked extra receptors when
transplanted into mice.
Tags: checkpoint inhibitors, Clinical Research, immunotherapy,
Lung Cancer, McGarry Houghton, Ovarian
Cancer, pembrolizumab, Philip D Greenberg, solid tumors, T
cell, t
cell therapy,
Transplant and Immunotherapy